About this trial
This study aims to evaluate the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in the management of pleural diseases.
Eligibility criteria
Qualifiers
Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
Age: Adults aged 18 years and older
Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.
Disqualifiers
Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
Trial design
Treatments tested in this trial
- thoracoscopic pleural biopsy.